Evidence map›Paper›PMID 26545814›Full record

ArticleGenes & development2015

Biochemical identification of new proteins involved in splicing repression at the Drosophila P-element exonic splicing silencer.

Lucas Horan, Jiro C Yasuhara, Lori A Kohlstaedt, Donald C Rio

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lucas HoranDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California 94720, USA;
Jiro C YasuharaDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California 94720, USA;
Lori A KohlstaedtCalifornia Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, California 94720, USA;
Donald C RioDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California 94720, USA; California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, California 94720, USA; Center for RNA Systems Biology, University of California at Berkeley, Berkeley, California 94720, USA.
QB3 · USUniversity of California, Berkeley · US

Funding

BIOCHEMISTRY OF REGULATED PRE-MRNA SPLICING/DROSOPHILAR01GM061987 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI RIO, DONALD C · 2000 to 2010
$3.0M
Alternative pre-mRNA Splicing in DrosophilaR01GM097352 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI RIO, DONALD C · 2012 to 2015
$1.6M
Human THAP9-an active DNA transposaseR01GM104385 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI RIO, DONALD C · 2013 to 2016
$1.4M
Methods for purification of individual nuclear pre-messenger RNA-protein complexeR01GM094890 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI RIO, DONALD C · 2010 to 2013
$1.2M
LTQ XL Linear Quadrupole Ion Trap Mass SpectrometerS10RR025622 · NCRR · UNIVERSITY OF CALIFORNIA BERKELEY · PI KOHLSTAEDT, LORI · 2009 to 2009
$463k
Analysis of alternative splicing regulators and their in vivo functionsF32GM080943 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI YASUHARA, JIRO C. · 2008 to 2009
$56k
NCRR NIH HHS S10 RR025622NCRR NIH HHS S10RR025622NIGMS NIH HHS F32 GM080943NIGMS NIH HHS R01 GM061987NIGMS NIH HHS R01 GM094890NIGMS NIH HHS R01GM094890NIGMS NIH HHS R01 GM097352NIGMS NIH HHS R01GM097352NIGMS NIH HHS R01 GM104385NIGMS NIH HHS R01GM61987
6 · The paper itself

Abstract

Splicing of the Drosophila P-element third intron (IVS3) is repressed in somatic tissues due to the function of an exonic splicing silencer (ESS) complex present on the 5' exon RNA. To comprehensively characterize the mechanisms of this alternative splicing regulation, we used biochemical fractionation and affinity purification to isolate the silencer complex assembled in vitro and identify the constituent proteins by mass spectrometry. Functional assays using splicing reporter minigenes identified the proteins hrp36 and hrp38 and the cytoplasmic poly(A)-binding protein PABPC1 as novel functional components of the splicing silencer. hrp48, PSI, and PABPC1 have high-affinity RNA-binding sites on the P-element IVS3 5' exon, whereas hrp36 and hrp38 proteins bind with low affinity to the P-element silencer RNA. RNA pull-down and immobilized protein assays showed that hrp48 protein binding to the silencer RNA can recruit hrp36 and hrp38. These studies identified additional components that function at the P-element ESS and indicated that proteins with low-affinity RNA-binding sites can be recruited in a functional manner through interactions with a protein bound to RNA at a high-affinity binding site. These studies have implications for the role of heterogeneous nuclear ribonucleoproteins (hnRNPs) in the control of alternative splicing at cis-acting regulatory sites.

Indexed as

AnimalsDrosophila melanogasterDrosophila ProteinsExonsGene Expression RegulationGenes, ReporterHeterogeneous-Nuclear RibonucleoproteinsMass SpectrometryNuclear ProteinsProtein BindingRecombinant ProteinsRibonucleoproteinsRNA InterferenceRNA PrecursorsRNA SplicingSilencer Elements, TranscriptionalDrosophila ProteinsHeterogeneous-Nuclear RibonucleoproteinsHrb27C protein, DrosophilaHrb87F protein, DrosophilaHRB98DE protein, DrosophilaNuclear ProteinsRecombinant ProteinsRibonucleoproteinsRNA Precursorsexonic splicing silencerspre-mRNA splicingsplicing repression

Identifiers

PMID26545814
PMCPMC4647562
OpenAlexW2169727804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.